To the Editor:
Data obtained using the multiple inert gas elimination technique show that hypoxemia in acute respiratory distress syndrome arises from regions with shunt and/or low / mismatch (1) but, more importantly, show no diffusion limitation of oxygen uptake into the pulmonary capillaries. Hypoxemia in patients with coronavirus disease (COVID-19)–associated lung disease may also be reasonably believed to result from / mismatch and shunt, but this has not been tested by definitive means. With this as brief background, we read the interesting study by Reynolds and colleagues (2), who used contrast-enhanced transcranial Doppler (TCD) after injection of agitated saline to detect transpulmonary transit of microbubbles as evidence for pulmonary microvascular dilatations in patients with severe COVID-19, a finding noted at autopsy (3). The authors made three key observations: 1) 83% of patients had detectable microbubbles with a median of 8 detected, 2) the PaO2/FiO2 was inversely correlated with the number of microbubbles, and 3) the number of microbubbles was inversely correlated to lung compliance. On the basis of their findings, they suggest that these pulmonary microvascular dilatations may explain the disproportionate degree of hypoxemia in some patients with COVID-19–associated lung injury akin to the perfusion–diffusion limitation for oxygen uptake occurring in the greatly enlarged pulmonary microvascular dilations of hepatopulmonary syndrome, as discussed in the accompanying editorial by DuBrock and Krowka (4).
We find several problems with the interpretation of these results. First, patent foramen ovale (PFO) is rather common, and because PFO presence was not examined in this study, we cannot rule out this as a contribution to their TCD microbubble detection. It would have been useful for the investigators to have performed TCD in patients with equally severe acute respiratory distress syndrome as a control group to detect whether the two conditions differ in this regard with their methodology. Second, the issue is not one of TCD sensitivity to detect microbubbles (5) but rather whether the microbubbles represent a cause of meaningful gas exchange derangement. For example, Stickland and colleagues (6) studied animals without PFO with a similar amount of bubble transit on transthoracic echocardiography, which are a result of naturally occurring intrapulmonary arterial–venous anastomoses. Despite a large amount of bubble contrast traversing the pulmonary circulation and appearing in the left ventricle, there was no evidence for a diffusion limitation of oxygen, and the actual shunt quantified by both 25 μm microspheres and the multiple inert gas elimination technique was small (<1.5% of Q̇). These data also showed that, although contrast echocardiography is extremely sensitive, it is nonspecific and frequently detects very small anatomical shunts that are <1% of Q̇ and of trivial importance for gas exchange. Consequently, the nonquantitative nature of transthoracic echocardiography and/or TCD does not permit any conclusions as to whether hypoxemia is caused by the putative microvascular dilatations described by Ackermann and colleagues (3) and others. Although the autopsy data show congested capillaries and slightly increased diameters, any comparison with the far greater vessel dilation (up to 100 μm) and the perfusion–diffusion limitation in hepatopulmonary syndrome is tenuous (4). It is more likely that the correlations of the TCD bubble score with compliance and the severity of hypoxemia as assessed by the PaO2/FiO2 simply reflect the amount of lung involvement with shunt and low / ratios, with TCD bubble detection from a PFO and/or recruitment of intrapulmonary arterial–venous anastomoses because of hypoxia, higher Q̇, and/or increased pulmonary artery pressure (6).
| 1. | Dantzker DR, Brook CJ, Dehart P, Lynch JP, Weg JG. Ventilation-perfusion distributions in the adult respiratory distress syndrome. Am Rev Respir Dis 1979;120:1039–1052. |
| 2. | Reynolds AS, Lee AG, Renz J, DeSantis K, Liang J, Powell CA, et al. Pulmonary vascular dilatation detected by automated transcranial doppler in COVID-19 pneumonia. Am J Respir Crit Care Med 2020;202:1037–1039. |
| 3. | Ackermann M, Verleden SE, Kuehnel M, Haverich A, Welte T, Laenger F, et al. Pulmonary vascular endothelialitis, thrombosis, and angiogenesis in COVID-19. N Engl J Med 2020;383:120–128. |
| 4. | DuBrock HM, Krowka MJ. Bubble trouble in COVID-19. Am J Respir Crit Care Med 2020;202:926–928. |
| 5. | Katsanos AH, Psaltopoulou T, Sergentanis TN, Frogoudaki A, Vrettou AR, Ikonomidis I, et al. Transcranial doppler versus transthoracic echocardiography for the detection of patent foramen ovale in patients with cryptogenic cerebral ischemia: a systematic review and diagnostic test accuracy meta-analysis. Ann Neurol 2016;79:625–635. |
| 6. | Stickland MK, Tedjasaputra V, Seaman C, Fuhr DP, Collins SÉ, Wagner H, et al. Intra-pulmonary arteriovenous anastomoses and pulmonary gas exchange: evaluation by microspheres, contrast echocardiography and inert gas elimination. J Physiol 2019;597:5365–5384. |
Supported by NIH grants R01HL129990 and R01HL119201 (S.R.H.).
Originally Published in Press as DOI: 10.1164/rccm.202010-3800LE on November 18, 2020
Author disclosures are available with the text of this letter at www.atsjournals.org.
